morphinans and morphinandienone

morphinans has been researched along with morphinandienone* in 6 studies

Other Studies

6 other study(ies) available for morphinans and morphinandienone

ArticleYear
A new morphinandienone alkaloid from the stems of Fissistigma tungfangense.
    Natural product research, 2019, Volume: 33, Issue:3

    A new morphinandienone alkaloid, fissistigmine A (1), together with three known alkaloids (2-4), were isolated and identified from the stems of Fissistigma tungfangense. Among them, fissistigmine A (1) represents the first example of a novel naturally occurring morphinandienone alkaloid with a unique cleavage of the C-9-N-17 bond. All isolated compounds were evaluated for their anti-rheumatoid arthritis activities via examining their anti-proliferative effects on synoviocytes in vitro. Compound 1 exhibited inhibitory effect on the proliferation of synoviocytes with an IC

    Topics: Alkaloids; Annonaceae; Antirheumatic Agents; Cell Proliferation; Morphinans; Plant Stems; Synoviocytes

2019
Milonine, a Morphinandienone Alkaloid, Has Anti-Inflammatory and Analgesic Effects by Inhibiting TNF-α and IL-1β Production.
    Inflammation, 2017, Volume: 40, Issue:6

    Milonine is a morphinandienone alkaloid from Cissampelos sympodialis Eichl (Menispermaceae), a plant used in Brazil to treat inflammatory disorders. In this study, we evaluated the anti-inflammatory and analgesic activity of milonine (MIL) by using classical experimental models of inflammation and nociception. The results showed that MIL reduced the paw edema formation induced by lipopolysaccharide, prostaglandin E

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Interleukin-1beta; Morphinans; Nociceptive Pain; Rats; Tumor Necrosis Factor-alpha

2017
Intrathecal medications in post-herpetic neuralgia.
    Pain medicine (Malden, Mass.), 2012, Volume: 13, Issue:8

    Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Bupivacaine; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Male; Morphinans; Neuralgia, Postherpetic; Retrospective Studies; Sufentanil; Treatment Outcome

2012
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Journal of neurochemistry, 2009, Volume: 111, Issue:2

    Control of the mesoaccumbens dopamine (DA) pathway by central serotonin(2C) receptors (5-HT(2C)Rs) involves different 5-HT(2C)R populations located within multiple brain areas. Here, using in vivo microdialysis in halothane-anesthetized rats, we assessed the role of medial prefrontal cortex (mPFC) 5-HT(2C)Rs in the control of basal and activated accumbal DA outflow, to identify the modalities of their recruitment and the role of 5-HT(2C)R constitutive activity. Intra-mPFC injection of the 5-HT(2C)R inverse agonist SB 206553 (0.5 microg/0.2 microL), without effect by itself, decreased accumbal DA outflow induced by morphine (2.5-10 mg/kg, s.c.), haloperidol (0.01 mg/kg, s.c.) or GBR 12909 (2.5 mg/kg, i.p.). Conversely, intra-mPFC injection of the 5-HT(2C)R antagonist SB 242084 (0.5 microg/0.2 microL), without effect by itself, decreased the effect of 10 mg/kg morphine, the only drug enhancing basal 5-HT outflow in the mPFC. The inhibitory effect of SB 206553 on 2.5 mg/kg morphine-stimulated DA outflow was suppressed by the concomitant intra-mPFC injection of SB 242084. Finally, changes of basal DA outflow induced by the 5-HT(2C)R agonist Ro 60-0175 (3 mg/kg, i.p.) or SB 206553 (5 mg/kg, i.p.) were unaffected by intra-mPFC injection of SB 242084. These results, showing that 5-HT(2C)R antagonist and inverse agonist behave differently in vivo, demonstrate that mPFC 5-HT(2C)Rs facilitate activated accumbal DA outflow and that 5-HT(2C)R constitutive activity participates in this interaction.

    Topics: Aminopyridines; Analgesics, Opioid; Animals; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Ethylamines; Extracellular Space; Haloperidol; Indoles; Male; Microdialysis; Microinjections; Morphinans; Neural Pathways; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2009
The efficient synthesis of morphinandienone alkaloids by using a combination of hypervalent iodine(III) reagent and heteropoly acid.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2004, Oct-11, Volume: 10, Issue:20

    The non-phenolic coupling reaction of benzyltetrahydroisoquinolines (laudanosine derivatives) by using a hypervalent iodine(III) reagent is described. In general, chemical oxidation of laudanosine gives glaucine. In contrast to general chemical oxidizing reagent systems, the novel use of reagent combination of phenyliodine bis(trifluoroacetate) (PIFA), and heteropoly acid (HPA) afforded morphinandienone alkaloids in excellent yields. In order to achieve the coupling reaction with simple reaction procedure, the use of HPA supported on silica gel instead of HPA was demonstrated and sufficient yield was exerted again. The present reagent system, PIFA/HPA, was also applied to the oxidation of other non-phenolic benzyltetrahydroisoquinolines and the high yield conversion to morphinandienones was accomplished.

    Topics: Acids; Alkaloids; Iodine; Isoquinolines; Molecular Structure; Morphinans; Oxidation-Reduction

2004
Morphinandienone alkaloids from Dehaasia longipedicellata.
    Fitoterapia, 2004, Volume: 75, Issue:7-8

    Five morphinoid alkaloids have been isolated from Dehaasia longipedicellata, namely (-) pallidine, a new alkaloid (+) pallidinine (1), (+)-milonine, (-) 8,14-dehydrosalutaridine and (-) sinoacutine.

    Topics: Alkaloids; Humans; Lauraceae; Magnetic Resonance Spectroscopy; Morphinans; Phytotherapy; Plant Extracts

2004